You have read all your free articles, to continue reading subscribe to read the rest of this content.
Lobsor Pharmaceuticals has reported that following Swedish MPA market approval in October 2018, the Swedish Dental and Pharmaceutical Benefits Agency (TLV) has included Lecigon on Sweden’s list of reimbursed drugs. A major milestone "This marks a major milestone as Sweden becomes the first countAlready a subscriber Login You have read…
In response to Russia's military attack on Ukraine, NordForsk has decided that co-operation projects with Russia will be suspended. "Following the attack on Ukraine, both the Nordic Council of Ministers and the authorities in the Nordic countries have decided to halt cooperation with Russia in a Already a subscriber Login…
The US Food and Drug Administration (FDA) has approved Farxiga (dapagliflozin) to reduce the risk of hospitalisation for heart failure (hHF) in adults with type-2 diabetes (T2D) and established cardiovascular disease (CVD) or multiple cardiovascular (CV) risk factors. The approval is based on resAlready a subscriber Login You have read…
NeuroVive Pharmaceutical has made a partial acquisition of British company Isomerase Therapeutics with the overall goal to strengthen the partnership and accelerate NeuroVive’s research and development program. The acquisition aims to further enhance the collaboration and to ensure that NeuroVAlready a subscriber Login You have read all your free articles, to…
